GLUE   $5.31  -2.57% Market Closed After Close 5.31 0.0

Monte Rosa Therapeutics Inc
Total Cash 262.20M
totalCashPerShare 4.273
EBITDA -131.78M
Total Debt 44.36M
quickRatio 6.424
currentRatio 6.562
Total Revenue 5.76M
debtToEquity 19.743
Revenue/Share 0.097
ROA -0.27986
ROE -0.59506
grossProfits
freeCashflow -57.04M
operatingCashflow -61.00M
earningsGrowth
revenueGrowth
grossMargins 1.0
ebitdaMargins 0.0
operatingMargins -6.9525
profitMargins 0.0
enterpriseValue 120.90M
forwardPE -2.9144385
floatShares 36.60M
sharesOutstanding 61.37M
sharesShort 4.38M
sharesShortPriorMonth 3.06M
dateShortInterest
sharesPercentSharesOut 0.07%
heldPercentInsiders 0.01%
heldPercentInstitutions 0.87%
Short Ratio help_outline 11.58%
shortPercentOfFloat 0.13%
impliedSharesOutstanding
bookValue 3.664
Price To Book help_outline 1.49
earningsQuarterlyGrowth
netIncomeToCommon -130.41M
trailingEps -2.22%
forwardEps -1.87%
enterpriseToEbitda -0.92
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.49 3Q 2024
institutionsCount 116
lastUpdated Oct. 22, 2024, 12:45 a.m.